一种模拟细菌性膀胱炎治疗流体动力学方面的体外模型。
An in-vitro model simulating the hydrokinetic aspects of the treatment of bacterial cystitis.
作者信息
Greenwood D
出版信息
J Antimicrob Chemother. 1985 Jan;15 Suppl A:103-9. doi: 10.1093/jac/15.suppl_a.103.
PMID:3980320
Abstract
Various applications of an in-vitro model that simulates the hydrokinetic features of the treatment of bacterial cystitis are described. Results obtained correlate well with clinical observations, suggesting that the model has relevance in the elucidation of clinical problems.
摘要
描述了一种模拟细菌性膀胱炎治疗流体动力学特征的体外模型的各种应用。所获得的结果与临床观察结果密切相关，表明该模型在阐明临床问题方面具有相关性。
相似文献
1
An in-vitro model simulating the hydrokinetic aspects of the treatment of bacterial cystitis.一种模拟细菌性膀胱炎治疗流体动力学方面的体外模型。
J Antimicrob Chemother. 1985 Jan;15 Suppl A:103-9. doi: 10.1093/jac/15.suppl_a.103.
2
The assessment of antimicrobial activity in an in-vitro model of the treatment of bacterial cystitis.在细菌性膀胱炎治疗的体外模型中对抗菌活性的评估。
J Antimicrob Chemother. 1984 May;13 Suppl B:43-8. doi: 10.1093/jac/13.suppl_b.43.
3
4
Norfloxacin: activity against urinary tract pathogens and factors influencing the emergence of resistance.诺氟沙星：对尿路病原体的活性及影响耐药性产生的因素
J Antimicrob Chemother. 1984 Apr;13(4):315-23. doi: 10.1093/jac/13.4.315.
5
Laboratory evaluation of enoxacin: comparison with norfloxacin and nalidixic acid.依诺沙星的实验室评估：与诺氟沙星和萘啶酸的比较。
J Antimicrob Chemother. 1985 Jan;15(1):45-52. doi: 10.1093/jac/15.1.45.
6
[UTIPRO PLUS CAPSULE, A NEW INNOVATIVE APPROACH FOR THE TREATMENT OF CYSTITIS AND OTHER BACTERIAL URINARY TRACT INFECTIONS].[优替普罗胶囊，治疗膀胱炎及其他细菌性尿路感染的全新创新方法]
Akush Ginekol (Sofiia). 2016;55 Suppl 1 Pt 2:23-5.
7
[Norfloxacin treatment of acute cystitis in the female and bacterial prostatitis].
Fortschr Med. 1985 Feb 28;103(8):225-8.
8
Factors governing the emergence of resistance to nalidixic acid in treatment of urinary tract infection.在治疗尿路感染中，影响对萘啶酸产生耐药性的因素。
Antimicrob Agents Chemother. 1977 Dec;12(6):678-81. doi: 10.1128/AAC.12.6.678.
9
An in vitro model for assessing optimum antibiotic dosage in urinary tract infection.一种用于评估尿路感染最佳抗生素剂量的体外模型。
Infection. 1980;Suppl 1:35-8. doi: 10.1007/BF01644933.
10
The activity of pipemidic acid and piromidic acid against Escherichia coli in static culture and in conditions stimulating the treatment of bacterial cystitis.
J Appl Bacteriol. 1978 Apr;44(2):191-7. doi: 10.1111/j.1365-2672.1978.tb00790.x.
引用本文的文献
1
Predicting Antimicrobial Activity at the Target Site: Pharmacokinetic/Pharmacodynamic Indices versus Time-Kill Approaches.预测靶部位的抗菌活性：药代动力学/药效学指标与时间杀菌法
Antibiotics (Basel). 2021 Dec 4;10(12):1485. doi: 10.3390/antibiotics10121485.
2
Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC.抗感染药物的药代动力学和药效学问题：杀菌曲线与最低抑菌浓度
Antimicrob Agents Chemother. 2004 Feb;48(2):369-77. doi: 10.1128/AAC.48.2.369-377.2004.
3
Activity of the trometamol salt of fosfomycin in an in vitro model of the treatment of bacterial cystitis.
Infection. 1986 Jul-Aug;14(4):186-9. doi: 10.1007/BF01645261.
4
Activity of fosmidomycin in an in vitro model of the treatment of bacterial cystitis.
Infection. 1987 Nov-Dec;15(6):465-8. doi: 10.1007/BF01647239.
Zotero 插件